Ho Maykin
Insider CIK 1646395 · BMRN Director · AGIO Director · NMRA Director · PRXL Director · FGEN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 19,848 | SEC↗ |
| KYNB KYNTRA BIO, INC. | A Award deriv | 2026-06-12 | 2026-06-17 | 7,000 | — | $0 | 7,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-06-02 | 2026-06-04 | 7,490 | — | $0 | 35,500 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 80,000 | — | $0 | 80,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 17,032 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2025-06-04 | 2025-06-06 | 120,000 | — | $0 | 120,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 95,586 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 27,802 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 28,571 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 95,586 | — | $0 | 95,586 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 27,802 | — | $0 | 27,802 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 28,571 | — | $0 | 28,571 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-05-20 | 2025-05-22 | 6,650 | — | $0 | 28,010 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 95,586 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 28,571 | — | $0 | 28,571 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 27,802 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 28,571 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 95,586 | — | $0 | 95,586 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 27,802 | — | $0 | 27,802 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 11,774 | — | $0 | 11,774 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 2,120 | — | $0 | 2,120 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 28,571 | — | $0 | 28,571 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-06-13 | 2024-06-17 | 3,388 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2024-06-13 | 2024-06-14 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-06-13 | 2024-06-17 | 3,388 | — | $0 | 14,912 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2024-06-05 | 2024-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-05-21 | 2024-05-23 | 4,720 | — | $0 | 21,360 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2023-09-14 | 2023-09-18 | 27,802 | — | $0 | 27,802 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2023-06-21 | 2023-06-23 | 4,975 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2023-06-21 | 2023-06-23 | 4,975 | — | $0 | 11,524 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 18,958 | — | $0 | 18,958 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 3,388 | — | $0 | 3,388 | SEC↗ |
| FGEN FIBROGEN INC | S Sale | 2023-06-08 | 2023-06-09 | 2,295 | $16.79 | $38.5K | 37,726 | SEC↗ |
| FGEN FIBROGEN INC | S Sale | 2023-06-08 | 2023-06-09 | 6,225 | $17.68 | $110.1K | 31,501 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2023-06-07 | 2023-06-09 | 12,666 | — | $0 | 12,666 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2023-06-07 | 2023-06-09 | 8,289 | — | $0 | 40,021 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-05-23 | 2023-05-24 | 4,190 | — | $0 | 16,640 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 4,975 | — | $0 | 4,975 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 29,307 | — | $0 | 29,307 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2022-06-16 | 2022-06-21 | 25,684 | — | $0 | 25,684 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2022-06-16 | 2022-06-21 | 15,777 | — | $0 | 31,732 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-05-24 | 2022-05-26 | 4,980 | — | $0 | 12,450 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 6,549 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 4,964 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2021-05-26 | 2021-05-28 | 7,800 | — | $0 | 7,800 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2021-05-26 | 2021-05-28 | 4,700 | — | $0 | 15,955 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-05-25 | 2021-05-27 | 5,120 | — | $0 | 7,470 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 1,585 | — | $0 | 1,585 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 8,888 | — | $0 | 8,888 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-02-17 | 2021-02-19 | 2,350 | — | $0 | 2,350 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2020-06-04 | 2020-06-08 | 7,800 | — | $0 | 7,800 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2020-06-04 | 2020-06-08 | 4,700 | — | $0 | 11,255 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 3,278 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 8,096 | — | $0 | 8,096 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 1,686 | — | $0 | 1,686 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2019-06-05 | 2019-06-07 | 7,800 | — | $0 | 7,800 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2019-06-05 | 2019-06-07 | 4,700 | — | $0 | 6,555 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 1,400 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 1,878 | — | $0 | 1,878 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 8,919 | — | $0 | 8,919 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2018-12-06 | 2019-02-07 | 10,400 | — | $0 | 10,400 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2018-12-06 | 2019-02-07 | 3,008 | — | $0 | 3,008 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2018-12-06 | 2019-02-07 | 1,855 | — | $0 | 1,855 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2018-12-05 | 2018-12-07 | 10,400 | — | $0 | 10,400 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2018-12-05 | 2018-12-07 | 3,008 | — | $0 | 3,008 | SEC↗ |
| FGEN FIBROGEN INC | A Award | 2018-12-05 | 2018-12-07 | 1,855 | — | $0 | 1,855 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 5,700 | — | $0 | 5,700 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 1,400 | — | $0 | 1,400 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | D To issuer | 2017-09-29 | 2017-10-04 | 6,612 | — | $0 | 0 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | A Award | 2017-09-08 | 2017-09-11 | 1,823 | — | $0 | 6,612 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 8,000 | — | $0 | 8,000 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | A Award | 2016-09-15 | 2016-09-16 | 2,369 | — | $0 | 4,789 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-23 | 8,000 | — | $0 | 29,250 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | A Award | 2015-09-10 | 2015-09-11 | 2,420 | — | $0 | 2,420 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-26 | 21,250 | — | $0 | 21,250 | SEC↗ |